We are live on ! Find out more
IGMS

IGM Biosciences

Delisted

IGMS was delisted on the 13th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$27.1M +$100K +11,845 +0.4%
BBA
2
Baker Bros. Advisors
New York
$26.4M +$4.7K +554 +0%
RG
3
Redmile Group
California
$24.8M
AG
4
Artal Group
Luxembourg
$21.1M
Fidelity Investments
5
Fidelity Investments
Massachusetts
$17.8M +$15.7K +1,853 +0.1%
RCM
6
RA Capital Management
Massachusetts
$7.83M
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.52M +$1.72M +202,719 +29%
BlackRock
8
BlackRock
New York
$7.27M +$117K +13,745 +2%
Millennium Management
9
Millennium Management
New York
$6.41M -$1.84M -216,600 -22%
GPP
10
Great Point Partners
Connecticut
$5.14M +$978K +115,317 +23%
Goldman Sachs
11
Goldman Sachs
New York
$3.82M -$1.83M -215,196 -32%
ECM
12
ExodusPoint Capital Management
New York
$3.79M +$3.85M +453,898 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.44M +$612K +72,115 +33%
State Street
14
State Street
Massachusetts
$2.41M +$236K +27,848 +11%
OM
15
Opaleye Management
Massachusetts
$2.18M +$1.68M +197,500 +311%
RPAM
16
Rhenman & Partners Asset Management
Sweden
$1.67M
CS
17
Candriam SCA
Luxembourg
$1.46M
First Manhattan
18
First Manhattan
New York
$1.44M +$1.46M +172,200 New
SB
19
Samsara BioCapital
California
$1.29M
Northern Trust
20
Northern Trust
Illinois
$1.13M +$127K +15,009 +12%
GCP
21
GSA Capital Partners
United Kingdom
$1.11M +$224K +26,358 +25%
Hudson Bay Capital Management
22
Hudson Bay Capital Management
Connecticut
$1.04M +$1.05M +124,260 New
BC
23
Bruce & Co
Illinois
$1M +$551K +65,000 +118%
Charles Schwab
24
Charles Schwab
California
$833K +$21K +2,472 +3%
Renaissance Technologies
25
Renaissance Technologies
New York
$759K -$722K -85,100 -48%